Ozempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs
The Biden administration is expanding coverage of anti-obesity drugs such as Ozempic and Wegovy for people with Medicare and Medicaid through a new proposal from the Department of Health and Human Services, a White House official says. Medicare currently ...
The Biden administration is proposing changes to Medicare Advantage plans designed to alleviate coverage barriers ...
The Biden administration is set to propose legislation allowing Medicare and Medicaid to cover the cost of GLP-1 obesity ...
WASHINGTON — Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback